MacGregor, T., Carter, R., Gillies, R., Findlay, J., Kartsonaki, C., Castro-Giner, F., . . . Sharma, R. (2018). Translational study identifies XPF and MUS81 as predictive biomarkers for oxaliplatin-based peri-operative chemotherapy in patients with esophageal adenocarcinoma. Nature Publishing Group.
Style de citation Chicago (17e éd.)MacGregor, T., et al. Translational Study Identifies XPF and MUS81 as Predictive Biomarkers for Oxaliplatin-based Peri-operative Chemotherapy in Patients with Esophageal Adenocarcinoma. Nature Publishing Group, 2018.
Style de citation MLA (9e éd.)MacGregor, T., et al. Translational Study Identifies XPF and MUS81 as Predictive Biomarkers for Oxaliplatin-based Peri-operative Chemotherapy in Patients with Esophageal Adenocarcinoma. Nature Publishing Group, 2018.